Investor insights
Sectors invested in
Regenerative Medicine1
Genetics1
Cytotoxic T Lymphocytes1
Poseida1
piggyBac®1
Prostate Cancer1
Gene Therapy1
Cell Therapy1
Gene Editing1
piggyBac® DNA Modification System1
Multiple Myeloma1
Non-viral1
CAR-T cells1
TAL-CLOVER™1
Therapeutics1
Oncology1
Biopharma1
Genome Engineering1
Cas-CLOVER™1
Transposon1
Funding rounds participated in
$142M sweet spot round size
Most of their 1 investments are in rounds between $142M and $142M
Basic info
Industry
financial services
Date founded
2007
Investments made
P
Poseida Therapeutics, Inc. raised $142M on April 22, 2019
Investors: Aisling Capital, Longitude Capital, Vivo Capital, Rapha Capital Management, LLC, Perceptive Advisors, Malin Corporation plc and PENTWATER CAPITAL MANAGEMENT LP